Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide Mononitrate Gel in Anal Fissure and Healthy Volunteers
NCT02667535Phase 1Withdrawn
- Sponsor
- Biolab Farmacêutica
- Start
- Jul 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of isosorbide mononitrate in anal fissure (4 arms), sponsored by Biolab Farmacêutica. Primary endpoints: Area under the curve time zero - last at 7 days, Area under the curve time zero - infinite at 7 days and 2 more. Planned start Jul 2017; status: withdrawn.
02
Drugs
isosorbide mononitrate
03
Conditions
anal fissure
Beyond the preview
Go deeper on NCT02667535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02667535.